Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas

Published

Journal Article (Academic article)

Full Text

Duke Authors

Cited Authors

  • Pishvaian, M; Morse, MA; McDevitt, J; Norton, JD; Ren, S; Robbie, GJ; Ryan, PC; Soukharev, S; Bao, H; Denlinger, CS

Published Date

  • December 1, 2016

Published In

Volume / Issue

  • 15 / 4

Start / End Page

  • 345 - 351

Published By

Pages

  • 7

Electronic International Standard Serial Number (EISSN)

  • 1938-0674

International Standard Serial Number (ISSN)

  • 1533-0028

Digital Object Identifier (DOI)

  • 10.1016/j.dcc.2016.07.009

Language

  • English